EVERSEPT PARTNERS, LP – Alnylam Pharmaceuticals, Inc. Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$0
portfolio value
EVERSEPT PARTNERS, LP quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -78.98K shares | -11.52M | $200.16 | 0 |
| Q2 2022 | share | Increase | +49.40% | 26.11K shares | 2.88M | $145.85 | 78.98K |
| Q1 2022 | share | Decrease | -24.73% | -17.36K shares | -3.27M | $163.29 | 52.87K |
| Q4 2021 | share | Increase | +18.58% | 11.00K shares | 727K | $171.03 | 70.24K |
| Q3 2021 | share | Increase | +15.83% | 8.09K shares | 2.51M | $188.81 | 59.23K |
| Q2 2021 | share | Decrease | -36.82% | -29.80K shares | -2.75M | $169.52 | 51.13K |
| Q1 2021 | share | Increase | 0.00% | 80.93K shares | 11.42M | $141.19 | 80.93K |
| Q4 2019 | share | Decrease | -100.00% | -92.04K shares | -7.40M | $115.17 | 0 |
| Q3 2019 | share | Increase | +5.62% | 4.9K shares | 1.07M | $80.42 | 92.04K |
| Q2 2019 | share | Increase | 0.00% | 87.14K shares | 6.32M | $72.56 | 87.14K |
| Q3 2018 | share | Decrease | -100.00% | -63.49K shares | -6.25M | $87.52 | 0 |
| Q2 2018 | share | Decrease | -19.52% | -15.4K shares | -3.14M | $98.49 | 63.49K |
| Q1 2018 | share | Increase | 0.00% | 78.89K shares | 9.39M | $119.1 | 78.89K |